Effect of Perampanel on Peritumoral Hyperexcitability in HGG

Clinical trial NCT04497142 · COMPLETED

Trial details

NCT number: NCT04497142
Sponsor: Dana-Farber Cancer Institute
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Glioma, Malignant Surgery Seizures

Start date: 2020-11-05
Primary completion: 2023-05-16
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.